---
schema_version: "secwatch.filing_event.v1"
accession: "0000899923-21-000097"
form_type: "8-K"
ticker: "MYGN"
cik: "0000899923"
company_name: "MYRIAD GENETICS INC"
filed_at: "2021-12-14T23:59:59+00:00"
generated_at: "2026-06-28T01:29:46.375933+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Myriad Genetics promotes Nicole Lambert to COO effective Jan 1, 2022

## Summary
- Appointed COO effective Jan 1, 2022; previously Group President over Oncology, Women's Health, International.
- Received one-time award of 10,000 time-based RSUs vesting over 4 years; base salary increased to $499,963.
- Lambert has 20-year tenure at Myriad; also serves on board of Arcus Biosciences (NYSE: RCUS).

## SEC filing metadata
- accession: 0000899923-21-000097
- form_type: 8-K
- ticker: MYGN
- cik: 0000899923
- company_name: MYRIAD GENETICS INC
- filed_at: 2021-12-14T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/899923/000089992321000097/0000899923-21-000097-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/899923/000089992321000097/mygn-20211214.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000899923-21-000097
- JSON: https://secwatch.observer/filing/0000899923-21-000097.json
- Plain text: https://secwatch.observer/filing/0000899923-21-000097.txt

## Key facts
- Executive change
  Nicole Lambert was appointed as Chief Operating Officer at MYRIAD GENETICS INC.
  - Action: appointed
  - Role: Chief Operating Officer
  source text: On December 14, 2021, Myriad Genetics, Inc. (the “Company”) announced that Nicole Lambert, currently serving as its Group President, Myriad Women's Health, Oncology and International, has been appointed Chief Operating Officer of the Company, effective January 1, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/899923/000089992321000097/0000899923-21-000097-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.